Vanguard Group Inc Imago Bio Sciences, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$15.03 - $35.96 $442,919 - $1.06 Million	29,469 Added 2.38%	1,265,741 $45.5 Million
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $3.24 Million - $4.47 Million	229,065 Added 22.74%	1,236,272 $18.6 Million
Q2 2022 Aug 12, 2022	BUY	$11.81 - $20.92 $2.53 Million - $4.48 Million	214,106 Added 27.0%	1,007,207 $13.5 Million
Q1 2022 May 13, 2022	BUY	$16.97 - $25.0 $5.49 Million - $8.08 Million	323,376 Added 68.84%	793,101 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$16.22 - $29.69 $4.31 Million - $7.89 Million	-265,656 Reduced 36.12%	469,725 $11.1 Million
Q3 2021 Nov 12, 2021	BUY	$16.0 - $28.84 $11.8 Million - $21.2 Million	735,381 New	735,381 $14.7 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.